FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006697079> ?p ?o ?g. }

• W2006697079 endingPage "151" @default.
• W2006697079 startingPage "144" @default.
• W2006697079 abstract "It has been shown that atrial natriuretic peptide (ANP), an endogenous vasodilator, dilates coronary arteries and decreases coronary vascular resistance. The purpose of this study was to determine whether an intravenous administration of ANP attenuated exercise-induced myocardial ischemia in 14 patients with stable effort angina pectoris.The first 12 patients (patients 1-12) who had exercise-induced ST segment depression underwent treadmill exercise testing and the last seven patients (patients 8-14) underwent the exercise 201Tl-single-photon emission computed tomography (SPECT) study while synthetic 28-amino acid alpha-human ANP (0.1 micrograms/kg per minute) or saline was intravenously infused in a double-blind, cross-over manner. The duration of exercise testing was the same during ANP and saline infusion, which was determined in preliminary exercise testings in each patient to cause a transient perfusion defect and/or ischemic ST segment depression. During saline infusion, all 12 patients developed exercise-induced ischemic ST segment depression, whereas no significant ST segment depression appeared during ANP infusion. Average ST segment depression during ANP infusion was significantly less (p < 0.01) than that during saline infusion (0.0 +/- 0.0 versus 0.2 +/- 0.1 mV, mean +/- SD). The averaged extent and severity scores assessed by 201Tl-SPECT were smaller (p < 0.05) during ANP infusion than during saline infusion (extent score: 0.22 +/- 0.20 versus 0.42 +/- 0.20; severity score: 18.77 +/- 23.45 versus 38.24 +/- 24.04, respectively). ANP decreased resting systolic blood pressure from 125 +/- 15 to 110 +/- 15 mm Hg (p < 0.01) but did not alter resting heart rate. At peak exercise, systolic blood pressure, heart rate, and the rate-pressure products did not differ during ANP and saline infusion. At peak exercise, plasma ANP increased from 98 +/- 45 to 4,383 +/- 2,782 pg/ml and cGMP increased from 3.6 +/- 1.7 to 34.5 +/- 16.1 pmol/ml during ANP infusion; values were significantly higher than those during saline infusion (from 96 +/- 42 to 133 +/- 66 pg/ml and from 3.4 +/- 1.8 to 4.6 +/- 1.8 pmol/ml, respectively).An intravenous administration of ANP attenuated exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Although the mechanism by which ANP attenuated myocardial ischemia was not defined, increased myocardial perfusion to the ischemic region might be an important factor." @default.
• W2006697079 created "2016-06-24" @default.
• W2006697079 creator A5033064888 @default.
• W2006697079 creator A5048481576 @default.
• W2006697079 creator A5065901351 @default.
• W2006697079 creator A5069646334 @default.
• W2006697079 creator A5075158215 @default.
• W2006697079 creator A5082234778 @default.
• W2006697079 creator A5082371954 @default.
• W2006697079 date "1993-01-01" @default.
• W2006697079 modified "2023-10-14" @default.
• W2006697079 title "Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris." @default.
• W2006697079 cites W1605314587 @default.
• W2006697079 cites W1996649628 @default.
• W2006697079 cites W2012503465 @default.
• W2006697079 cites W2015734320 @default.
• W2006697079 cites W2018109773 @default.
• W2006697079 cites W2019932147 @default.
• W2006697079 cites W2025691538 @default.
• W2006697079 cites W2028079895 @default.
• W2006697079 cites W2033619252 @default.
• W2006697079 cites W2036158099 @default.
• W2006697079 cites W2050830159 @default.
• W2006697079 cites W2087529873 @default.
• W2006697079 cites W2093043112 @default.
• W2006697079 cites W2099601233 @default.
• W2006697079 cites W2124220331 @default.
• W2006697079 cites W2166079697 @default.
• W2006697079 cites W2168090194 @default.
• W2006697079 cites W2410677307 @default.
• W2006697079 doi "https://doi.org/10.1161/01.cir.87.1.144" @default.
• W2006697079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8419001" @default.
• W2006697079 hasPublicationYear "1993" @default.
• W2006697079 type Work @default.
• W2006697079 sameAs 2006697079 @default.
• W2006697079 citedByCount "33" @default.
• W2006697079 crossrefType "journal-article" @default.
• W2006697079 hasAuthorship W2006697079A5033064888 @default.
• W2006697079 hasAuthorship W2006697079A5048481576 @default.
• W2006697079 hasAuthorship W2006697079A5065901351 @default.
• W2006697079 hasAuthorship W2006697079A5069646334 @default.
• W2006697079 hasAuthorship W2006697079A5075158215 @default.
• W2006697079 hasAuthorship W2006697079A5082234778 @default.
• W2006697079 hasAuthorship W2006697079A5082371954 @default.
• W2006697079 hasBestOaLocation W20066970791 @default.
• W2006697079 hasConcept C120770815 @default.
• W2006697079 hasConcept C126322002 @default.
• W2006697079 hasConcept C139719470 @default.
• W2006697079 hasConcept C146957229 @default.
• W2006697079 hasConcept C162324750 @default.
• W2006697079 hasConcept C164705383 @default.
• W2006697079 hasConcept C2771771 @default.
• W2006697079 hasConcept C2775915353 @default.
• W2006697079 hasConcept C2776867660 @default.
• W2006697079 hasConcept C2777397205 @default.
• W2006697079 hasConcept C2778069365 @default.
• W2006697079 hasConcept C2778198053 @default.
• W2006697079 hasConcept C2778425758 @default.
• W2006697079 hasConcept C2780395512 @default.
• W2006697079 hasConcept C42219234 @default.
• W2006697079 hasConcept C500558357 @default.
• W2006697079 hasConcept C58245268 @default.
• W2006697079 hasConcept C71924100 @default.
• W2006697079 hasConcept C84393581 @default.
• W2006697079 hasConceptScore W2006697079C120770815 @default.
• W2006697079 hasConceptScore W2006697079C126322002 @default.
• W2006697079 hasConceptScore W2006697079C139719470 @default.
• W2006697079 hasConceptScore W2006697079C146957229 @default.
• W2006697079 hasConceptScore W2006697079C162324750 @default.
• W2006697079 hasConceptScore W2006697079C164705383 @default.
• W2006697079 hasConceptScore W2006697079C2771771 @default.
• W2006697079 hasConceptScore W2006697079C2775915353 @default.
• W2006697079 hasConceptScore W2006697079C2776867660 @default.
• W2006697079 hasConceptScore W2006697079C2777397205 @default.
• W2006697079 hasConceptScore W2006697079C2778069365 @default.
• W2006697079 hasConceptScore W2006697079C2778198053 @default.
• W2006697079 hasConceptScore W2006697079C2778425758 @default.
• W2006697079 hasConceptScore W2006697079C2780395512 @default.
• W2006697079 hasConceptScore W2006697079C42219234 @default.
• W2006697079 hasConceptScore W2006697079C500558357 @default.
• W2006697079 hasConceptScore W2006697079C58245268 @default.
• W2006697079 hasConceptScore W2006697079C71924100 @default.
• W2006697079 hasConceptScore W2006697079C84393581 @default.
• W2006697079 hasIssue "1" @default.
• W2006697079 hasLocation W20066970791 @default.
• W2006697079 hasLocation W20066970792 @default.
• W2006697079 hasOpenAccess W2006697079 @default.
• W2006697079 hasPrimaryLocation W20066970791 @default.
• W2006697079 hasRelatedWork W2002614315 @default.
• W2006697079 hasRelatedWork W2011708516 @default.
• W2006697079 hasRelatedWork W2012589553 @default.
• W2006697079 hasRelatedWork W2035542774 @default.
• W2006697079 hasRelatedWork W2038249069 @default.
• W2006697079 hasRelatedWork W2088350087 @default.
• W2006697079 hasRelatedWork W2101122852 @default.
• W2006697079 hasRelatedWork W2102873241 @default.
• W2006697079 hasRelatedWork W2162496230 @default.
• W2006697079 hasRelatedWork W2914437518 @default.

• next